New gene test offers personalized treatment for inherited neuromuscular disorder
The gene, GFPT1, has been identified by researchers at Newcastle University working with international colleagues, as crucial in causing a variation of Congenital Myasthenic Syndrome (CMS).
The condition came to prominence in recent times in the U…